Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ   US4781601046

JOHNSON & JOHNSON (JNJ)

225
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Johnson & Johnson : FDA : J&J Unit Recalls Potentially Flammable Bone Putty

08/21/2012 | 06:13pm US/Eastern
Recommend:
0
   By Ben Fox Rubin 
 

The Food and Drug Administration said Johnson & Johnson (JNJ) unit Synthes last month initiated a recall on certain lots of bone putty, saying the medical product could catch fire during surgery.

The FDA gave the recall a Class I designation, its most serious type of recall.

The regulator said Synthes in early July issued a medical device recall letter, asking medical facilities to examine their inventories and immediately stop using specific lots of the putty. The product, called a hemostatic bone putty, is used to stop bone bleeding by creating a physical barrier along the edges of bones that have been damaged by trauma or cut during surgery.

The FDA said the putty could ignite under some conditions if contacted with certain surgical equipment.

The lots recalled were manufactured between July 6, 2011, and Dec. 14, 2011, and were distributed from Dec. 22, 2011, to June 25, 2012.

J&J in June completed its $19.7 billion purchase of medical-device maker Synthes. The health-care giant has worked to tackle a range of problem products, such as the bottles of children's Tylenol and other popular over-the-counter medicines, as well as some contact lenses and certain hip implants, that the company recalled due to manufacturing problems.

The company's shares closed Tuesday at $67.78 and were up 15 cents after hours. The stock is up 3.4% so far this year.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Recommend :
0
React to this article
Latest news on JOHNSON & JOHNSON
5h ago JOHNSON & JOHNSON : to buy private drug developer for $1.75 billion
10h ago JOHNSON & JOHNSON : buying Alios for $1.75B
11h ago JOHNSON & JOHNSON : Announces Agreement To Acquire Alios BioPharma
14h ago JOHNSON & JOHNSON : Australia paceman Johnson still remembers English taunts
18h ago JOHNSON & JOHNSON : Schedules Conference Call to Discuss 3Q 2014 Results
18h ago JOHNSON & JOHNSON : Sets Date for Third Quarter Results Conference Call
1d ago JOHNSON & JOHNSON : Power Morcellator News: UPMC Health System Suspension of Pow..
3d ago JOHNSON & JOHNSON : I read Law, but I'm a fashion designer – Johnson Iyaye
4d ago JOHNSON & JOHNSON : Is setting up new facility in ap
4d ago JOHNSON & JOHNSON : Three Xarelto Wrongful Death Lawsuits Recently Filed, Notes ..
Advertisement
Chart
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF